Join Tetra Tech in ensuring we all can continue to be resilient against the COVID-19 pandemic by implementing responsive Health & Safety (H&S) practices and resources.
Pharmaceutical companies have long experience in measuring the impact of their business programs. The same should apply to their access-to-medicine efforts. Richard Laing, from the Boston University (BU) School of Public Health and former World Health Organization official, says that many efforts to expand access to medicines fail to gather sufficient evidence on how effective they are.
How can we prevent the urbanization boom from becoming a health crisis? Making our cities into places of wellbeing, exciting growth and opportunity will require every sector to join forces on urban health, says Dr. Ann Aerts, Head of the Novartis Foundation.
On World Hypertension Day 2017, the Novartis Foundation and its partners, including Intel Corporation, the NCD Alliance, city governments and local partners, announce the launch of Better Hearts Better Cities, an innovative initiative to address the high rates of high blood pressure (hypertension) in low-income urban communities.
Novartis reaches agreement with Pakistan to supply medicines that address the rapid rise of chronic illness among poor people in the world's sixth most populous nation. Novartis Access medicines will be made available to the poorest population in Pakistan through hospitals under the Prime Minister’s National Health Insurance Program.
With increasing public health concerns associated with Legionnaires’ disease and waterborne healthcare associated infections (WHAIs), it’s not surprising that more than 200 healthcare professionals and building owners and operators attended Nalco Water’s April 20 conference in Baltimore on strategies to reduce the risk of waterborne pathogens.
In August 2016, FedEx hosted road safety advocates from 15 countries across the globe to participate in a two-week advocacy training course with the Global Alliance of NGOs for Road Safety. One of the advocates, Afef Ghenia, took what she learned in Memphis and managed to enact a
Gilead Sciences, Inc. today announced that it issued its Year in Review 2016, a combination of the company’s Annual Report and Corporate Social Responsibility report. This report provides an in-depth look into Gilead’s commitment to develop and deliver innovative therapies that change lives.
This Veterans and Military Families Month, we celebrate the strength, dedication, and sacrifices of former service members and their loved ones. CACI...
The communities where Chemours operates are also where we live, work, and play, and our mutual success is one and the same. We have a vested interest...
Everyone’s financial journey is different. We make intentional efforts to meet the individual needs of clients and communities through a diverse range...
